Fetal Medicine: Advanced Monitoring of Fetal Health During Pregnancy

Fetal medicine is a precise and advanced subspecialty focused on fetal health before birth, on early diagnosis of any abnormalities, and on the meticulous management of high-risk pregnancies. The field has matured significantly over recent decades thanks to advanced imaging and molecular testing, saving thousands of fetal lives every year and substantially improving pregnancy outcomes, in line with International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) guidance.

What is fetal medicine?

Fetal medicine is a specialised branch of obstetrics and gynaecology focused on:

• Assessing fetal growth and wellbeing throughout pregnancy
• Diagnosing congenital abnormalities early (in the first trimester whenever possible)
• Managing high-risk pregnancies
• In utero intervention in selected rare cases
• Counselling parents to support informed decision-making

A fetal medicine specialist undergoes advanced training in detailed ultrasound, genetic diagnosis, and management of critical cases. Membership of international bodies such as ISUOG or the Fetal Medicine Foundation (FMF) is a benchmark of specialist training.

Essential investigations by trimester

First-trimester screening (weeks 11–14)

• Nuchal translucency (NT) measurement: a detailed assessment of fluid behind the fetal neck, which detects Down syndrome and other abnormalities with 75–90% accuracy when combined with a blood test
• Combined first-trimester test: PAPP-A and β-hCG
• Confirmation of fetal heartbeat, size, and placental location
• Early survey of major fetal structures (brain, heart, limbs)
• NIPT for higher-risk mothers

Anomaly scan (weeks 18–22)

The most comprehensive scan of pregnancy, performed in detail by a fetal medicine specialist:

• Full anatomical survey of all fetal organs
• Detailed cardiac assessment (four-chamber view, valve flow, aorta, pulmonary artery)
• Brain, skull, and facial assessment
• Spine and neural assessment
• Renal and urinary tract evaluation
• Gastrointestinal tract assessment
• Limb and digit evaluation
• Fetal biometry (BPD, HC, AC, FL)
• Amniotic fluid, placenta, and umbilical cord assessment

Third-trimester investigations (weeks 28–40)

• Growth scans
• Doppler studies of umbilical and middle cerebral arteries
• Amniotic fluid assessment
• Non-stress test (NST)
• Biophysical profile (BPP)

Non-invasive prenatal testing (NIPT)

A revolutionary technique developed over the past decade:

• A simple maternal blood test after week 10
• Detects cell-free fetal DNA in maternal blood
• Up to 99% accuracy for Down syndrome
• High accuracy for Edwards and Patau syndromes
• 99.7% accuracy for fetal sex
• Can screen for sex chromosome aneuploidies and selected microdeletion syndromes
• Non-invasive — no risk to the fetus

NIPT does not replace ultrasound but complements it. ACOG recommends offering NIPT to all pregnant women regardless of age.

Invasive diagnostic procedures

These are reserved for situations requiring a definitive diagnosis:

Amniocentesis

• Performed between weeks 16–20
• Aspirates a small sample of amniotic fluid
• DNA is analysed for genetic disorders
• Miscarriage risk: 0.1–0.3% in experienced hands

Chorionic villus sampling (CVS)

• Performed between weeks 10–13 (earlier than amniocentesis)
• Takes a small placental sample
• Provides earlier genetic results
• Miscarriage risk: 0.2–0.5%

Cordocentesis

• A highly specialised procedure
• Used in rare cases for direct fetal blood sampling
• Useful in fetal anaemia and intrauterine infections

Conditions followed in fetal medicine

Intrauterine growth restriction (IUGR/FGR)

• Close ultrasound monitoring every two weeks
• Doppler studies of fetal blood flow
• Optimisation of delivery timing
• Medical intervention when indicated

High-risk pregnancy

• Maternal chronic disease (diabetes, hypertension, cardiac disease)
• Adverse obstetric history
• Advanced maternal age
• Pregnancy after IVF

Detected congenital abnormalities

• Postnatal care planning
• Referral to specialist centres when needed
• Fetal intervention in selected rare cases

Multiple pregnancy (twins)

• Monochorionic twins have specific complications (TTTS, sIUGR)
• Monitoring every 2–3 weeks from early pregnancy
• Laser therapy in TTTS

Fetal anaemia

• Monitoring middle cerebral artery peak systolic velocity
• Intrauterine blood transfusion in severe cases

Placenta praevia and accreta

• Accurate diagnosis and delivery planning
• Referral to tertiary centres when needed

Fetal therapeutic interventions

In very rare cases, the fetus can be treated directly inside the uterus:

• Blood transfusion for severe fetal anaemia
• Treatment of fetal arrhythmias
• Laser therapy for twin-to-twin transfusion syndrome (TTTS)
• Vesicoamniotic shunts for urinary tract obstruction
• Antenatal correction of diaphragmatic hernia (in selected global centres)

These complex procedures are only available in specialist tertiary centres worldwide.

The importance of early follow-up in high-risk pregnancy

Early and regular follow-up with a fetal medicine specialist is essential in:

• Maternal age over 35
• Family history of genetic disorders
• Pregnancy after IVF
• Maternal chronic disease (diabetes, hypertension, lupus, thrombophilia)
• Previous child with congenital anomalies
• Previous preterm births
• Previous pre-eclampsia
• Multiple pregnancy
• Use of medications that may affect the fetus

Lifestyle in high-risk pregnancy

• Regular follow-up with the medical team
• Strict adherence to scheduled appointments
• Supplementation (folate, iron, vitamin D, calcium)
• Balanced diet
• Complete avoidance of smoking, alcohol, and drugs
• Optimal control of chronic disease (diabetes, hypertension)
• Moderate exercise as advised
• Stress management and psychological support
• Awareness of warning signs that require immediate review

Warning signs requiring immediate review

• Vaginal bleeding
• Severe abdominal pain
• Severe headache unresponsive to simple analgesics
• Blurred vision or flashing lights
• Sudden severe swelling of hands and face
• Regular contractions before 37 weeks
• Vaginal fluid leakage
• Markedly reduced fetal movement
• High fever
• Severely raised blood pressure

Frequently asked questions

When should fetal medicine follow-up begin?

The first visit is typically at weeks 11–13 for the nuchal translucency scan. High-risk women need earlier follow-up from confirmation of pregnancy.

Does NIPT replace amniocentesis?

NIPT is a highly accurate screening test. A positive result requires confirmation by amniocentesis or CVS. A negative result is very strong reassurance and usually does not require confirmation.

Are ultrasound scans safe for the fetus?

Yes. Hundreds of studies over 60 years have not shown any harm from medical ultrasound use.

What happens if a fetal abnormality is detected?

It depends on the type:

• Some require only close monitoring
• Some need postnatal surgery in a specialist centre
• Some need rare fetal intervention
• Severe cases warrant extended family counselling

Does advanced maternal age inevitably mean abnormalities?

No. Older age increases the likelihood but does not make it certain. Many women over 40 deliver perfectly healthy children with appropriate follow-up.

Sources

• International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). Guidelines on fetal scanning.
• Fetal Medicine Foundation (FMF). Standards for first-trimester screening.
• American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin on prenatal screening.
• Royal College of Obstetricians and Gynaecologists (RCOG).
• World Health Organization (WHO). Antenatal care guidance.
• Cochrane Database of Systematic Reviews. Ultrasound for fetal assessment.

Medical disclaimer

This article provides general medical information for educational purposes only. It is not a substitute for personal medical advice, diagnosis, or treatment from a qualified healthcare professional. Every pregnancy is different. Please consult Dr. Haytham Ibrahim to discuss the follow-up plan that is right for your pregnancy.